UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 3
March-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2503580


Registration ID:
557312

Page Number

f433-f451

Share This Article


Jetir RMS

Title

Therapeutic Insights into Jamun (Syzygium cumini) Seed Extracts: Inhibition of Hep-2 Cancer Cell Growth and Beyond

Abstract

The seeds of Syzygium cumini, also referred to as jamun or black plum, contain a complex phytochemical profile that includes alkaloids, tannins, phenolic compounds, and flavonoids, all of which have shown promise as medicines. The anticancer effects of jamun seed extracts on human laryngeal carcinoma (Hep-2) cells are examined in this work. The findings showed that the seed extracts successfully and dose-dependently suppressed the growth of Hep-2 cancer cells. According to mechanistic study, the anticancer effect is mediated by stimulating apoptosis, interfering with the course of the cell cycle, and producing more reactive oxygen species (ROS), which causes oxidative stress in cancer cells. The extracts also shown anti-angiogenic qualities, which further slowed the growth of tumours. These results demonstrate the potential of extracts from jamun seeds as a natural, bioactive agent for supplementary cancer treatment, which calls for more research into their active ingredients and possible uses in medicine.

Key Words

Anti carcinoma, Eugenia jambolana, Human laryngeal epithelioma type 2 (Hep 2) cells

Cite This Article

"Therapeutic Insights into Jamun (Syzygium cumini) Seed Extracts: Inhibition of Hep-2 Cancer Cell Growth and Beyond", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 3, page no.f433-f451, March-2025, Available :http://www.jetir.org/papers/JETIR2503580.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Therapeutic Insights into Jamun (Syzygium cumini) Seed Extracts: Inhibition of Hep-2 Cancer Cell Growth and Beyond", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 3, page no. ppf433-f451, March-2025, Available at : http://www.jetir.org/papers/JETIR2503580.pdf

Publication Details

Published Paper ID: JETIR2503580
Registration ID: 557312
Published In: Volume 12 | Issue 3 | Year March-2025
DOI (Digital Object Identifier):
Page No: f433-f451
Country: Aurangabad, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00071

Print This Page

Current Call For Paper

Jetir RMS